A preliminary trial of lividomycin in patients with pulmonary tuberculosis.
D000328:Adult; D000368:Aged; D000606:Amino Sugars / Q000009:adverse effects / Q000627:therapeutic use; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006027:Glycosides / Q000627:therapeutic use*; D006801:Humans; D007294:Inositol / Q000009:adverse effects / Q000627:therapeutic use; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011859:Radiography; D013183:Sputum / Q000382:microbiology; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology
D000606:Amino Sugars; D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D006027:Glycosides; D007294:Inositol; D007538:Isoniazid; D013307:Streptomycin